PALPABLE SUBCUTANEOUS MALIGNANT LESIONS

Clinical trials for PALPABLE SUBCUTANEOUS MALIGNANT LESIONS explained in plain language.

Never miss a new study

Get alerted when new PALPABLE SUBCUTANEOUS MALIGNANT LESIONS trials appear

Sign up with your email to follow new studies for PALPABLE SUBCUTANEOUS MALIGNANT LESIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug combo aims to tackle Hard-to-Treat cancers

Disease control Ongoing

This trial tests an experimental drug called TRK-950 in combination with several standard anti-cancer treatments for people with advanced solid tumors, including colorectal, bladder, ovarian, and other cancers. The main goal is to find safe doses and understand side effects. Part…

Matched conditions: PALPABLE SUBCUTANEOUS MALIGNANT LESIONS

Phase: PHASE1 • Sponsor: Toray Industries, Inc • Aim: Disease control

Last updated Jun 27, 2026 14:01 UTC

PALPABLE SUBCUTANEOUS MALIGNANT LESIONS

Get alerted when new PALPABLE SUBCUTANEOUS MALIGNANT LESIONS trials appear

New drug combo aims to tackle Hard-to-Treat cancers